ELAROS host PPIE workshops as part of MammoScreen Project in Lisbon, Portugal In May 2024, ELAROS was lucky to join the rest of the MammoScreen Project partners in at the…
ELAROS wins Phase 2 funding through Innovate UKs Small Business Research Initiative for Open-OH project On the 15th of April 2024 ELAROS was named one of the five winners nationally…
MAMMOSCREEN takes part in the first Annual Meeting of the Cancer Mission Cluster “Prevention and early detection (Screening)” The first annual meeting of the “Prevention and early detection (screening)” Cluster…
MammoScreen launches the Hereditary Breast Cancer Questionnaire In August 2023, the Hereditary Breast Cancer Questionnaire was launched as part of the MammoScreen project that ELAROS is a part of. ELAROS worked…
ELAROS joins MammoScreen in organising webinar “Shaping the future of Breast Cancer screening: introducing the MammoScreen project” The first MammoScreen Webinar with Patient Advocates and Patient Advocay Groups was held on…
MAMMOSCREEN joins the cancer “Prevention and early detection (Screening)” cluster of EU funded projects It is with great pleasure that we announce that MAMMOSCREEN has joined the EU funded projects…
ROVER: ELAROS delivers an industrial visit to University of Florence ELAROS Director of Research and Development, Román Rocha Lawrence, delivered a two week industrial visit to the Università degli Studi…
MammoScreen holds its first in person consortium meeting On the 17th and 18th of May, ELAROS had the exciting opportunity to attend the first MammoScreen Consortium Meeting at London Southbank…
Mi-Trial Launches Innovative New Clinical Trials App And Portal To Improve Trial Participation And Outcomes Mi-Trial, a new company which has developed an innovative clinical trial companion system and app,…
ELAROS Appoints Scientific Director for New Innovate UK Project ELAROS is delighted to announce that Dr Thomas Richards will join the team from the 1st April 2022, in the new…